TITLE

Teva: GSK's latest headache

PUB. DATE
January 2007
SOURCE
PharmaWatch: CNS;Jan2007, Vol. 6 Issue 1, p16
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
The article focuses on the tentative approval received by Teva Pharmaceutical Industries Ltd. for sumatriptan succinate anti-migraine drug from the U.S. Food and Drug Administration. The firm has become the latest addition to companies that aim to challenge the Imitrex drug of GlaxoSmithKline. Sumatriptan tablets represent a valuable addition to the company's generics portfolio. The availability of generic sumatriptan in European countries has resulted in a decline in sales of Imitrex.
ACCESSION #
24003976

 

Related Articles

  • Teva: GSK's latest headache.  // PharmaWatch: Monthly Review;Jan2007, Vol. 6 Issue 1, p21 

    The article discusses the tentative approval received by Teva Pharmaceutical Industries Ltd. from the U.S. Food and Drug Administration for its sumatriptan succinate. Teva joins other companies who received tentative approval for the generic Imitrex or successfully settled patent litigation with...

  • FDA blocks Trexima approval again.  // PharmaWatch: CNS;Sep2007, Vol. 6 Issue 9, p15 

    The article reports that the U.S. Food and Drug Administration (FDA) has delayed the approval of Pozen Inc. and GlaxoSmithKline's Trexima for the second time in the U.S. Reportedly, the FDA delayed the first approval of this drug in January 2007 where additional safety data from clinical trials...

  • Week in Washington.  // BioWorld Insight;11/ 5/2012, Vol. 20 Issue 45, p6 

    The article reports that the U.S. Food & Drug Administration has approved the drug Synribo for treatment of chronic myelogenous leukemia which will be marketed by Teva Pharmaceutical Industries Ltd.

  • First-time generic approval.  // Formulary;Aug2009, Vol. 44 Issue 8, p224 

    The article reports that Ethinyl estradiol/norgestimate tablets from Teva Pharmaceutical Industries Ltd. has got the approval of the Food & Drug Administration (FDA) of the U.S.

  • FDA approves Teva's one-pill emergency contraceptive. Johnsen, Michael // Drug Store News;8/10/2009, Vol. 31 Issue 9, p83 

    The article reports on the approval for the emergency contraceptive Plan B One-Step from Teva Pharmaceuticals Industries Ltd. by the Food and Drug Administration (FDA) in the U.S. It notes that the product is a line extension of Plan B which changes the two-pill regimen to one pill. It adds that...

  • Teva Launches Generic Lovaza Capsules in the U.S.  // Nutraceuticals World;May2014, Vol. 17 Issue 4, p20 

    The article reports that pharmaceutical company Teva Pharmaceutical Industries Ltd. has announced the approval of its generic drugs for Lovaza capsules by the U.S. Food and Drug Administration (FDA) in 2014.

  • Teva receives FDA approval to market generic Aricept tablets.  // PharmaWatch: CNS;Jul2011, Vol. 10 Issue 7, p9 

    The article reports on the approval given by the U.S. Food and Drug Administration (FDA) to market the new abbreviated drug application (ANDA) of Teva Pharmaceutical Industries Ltd. which is the generic version of Aricept tablets for the treatment of Alzheimer's disease.

  • Zoloft patent expiration sparks battle royal.  // Drug Topics;7/24/2006, Vol. 150 Issue 14, p8 

    The article reports that the U.S. Food and Drug Administration has approved the generic version of Zoloft antidepressants of Teva Pharmaceutical Industries Ltd. and Roxane Laboratories Inc. Teva's version of the drug is in tablet form while Roxane's version of it is in liquid form. This move of...

  • Generic approvals may set off statin storm. LoBuono, Charlotte // Drug Topics;7/24/2006, Vol. 150 Issue 14, p10 

    The article reports on the approval of several generic versions of simvastatin by the U.S. Food and Drug Administration. Teva Pharmaceutical Industries Ltd. is gaining an exclusive rights to sell several dosages of simvastatin. Ranbaxy Pharmaceuticals Inc. is acquiring rights to sell 80...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics